Business Trip
A podcast by Greg Kubin & Matias Serebrinsky - Joi
59 Episoade
-
The state of psychedelics: Dr. Rachel Yehuda and Zach Haigney (live recording at Soho House)
Publicat: 05.06.2022 -
Empowering the next wave of psychedelic therapists: Journey Clinical
Publicat: 23.05.2022 -
Osmind and the future of electronic health records in psychedelic medicine
Publicat: 18.04.2022 -
Palo Santo on investing in 2nd gen psychedelics and public markets
Publicat: 21.03.2022 -
Designing psychedelic mindstates, with Mindstate Design Labs
Publicat: 10.02.2022 -
PsyMed Ventures, our venture fund to invest in psychedelic medicine & mental health tech
Publicat: 10.01.2022 -
MAPS PBC, rethinking the pharma business model and MDMA-assisted therapy
Publicat: 24.11.2021 -
On transformational ketamine therapy and running an integrative psychedelic clinic
Publicat: 28.10.2021 -
The new frontiers of DMT therapies
Publicat: 06.10.2021 -
Scaling Psilocybin Therapy: Compass Pathways' Lars Wilde
Publicat: 13.08.2021 -
Analyzing the atai Life Sciences IPO
Publicat: 10.06.2021 -
A 30 year journey towards ibogaine approval: Deborah Mash, CEO of DemeRx
Publicat: 04.05.2021 -
Clinical trials, media, reciprocity, open science: Founder of The Trip Report, Zach Haigney
Publicat: 16.03.2021 -
How to (legally) make psychedelic medicine: CEO of Psygen, Danny Motyka
Publicat: 24.02.2021 -
From serving medicine to company founder: NANA founder Flor Bollini
Publicat: 05.01.2021 -
Helping psychedelic practitioners through software: Maya Health CEO David Champion
Publicat: 19.10.2020 -
How to invest in psychedelic companies: Vine Ventures' Founder Ryan Zurrer
Publicat: 17.09.2020 -
Building a psychedelic media company: DoubleBlind's Shelby Hartman and Madison Margolin
Publicat: 13.08.2020 -
Dylan Beynon: ketamine-assisted therapy for anxiety and depression
Publicat: 21.06.2020
Business Trip tells the story of businesses at the frontier of mental health and brain health. Each episode features founders, investors, and researchers in psychedelics, neurotechnology, metabolic psychiatry, digital therapeutics, and more.
